Andrea Newkirk

Stock Analyst at Goldman Sachs

(0.54)

# 3,967

Out of 4,905 analysts

3

Total ratings

n/a

Success rate

-1.11%

Average return

Main Sectors:

Top Industries:

Biotechnology Drug Manufacturers - Specialty & Generic

Stocks Rated by Andrea Newkirk

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	ALKS Alkermes	Initiates: Buy	$43	$29.22	+47.16%	1	Jul 15, 2025
	RVMD Revolution Medicines	Initiates: Buy	$65	$38.29	+69.76%	1	Jul 15, 2025
	ETNB 89bio	Initiates: Neutral	$11	$10.49	+4.86%	1	Mar 14, 2025

Alkermes

Jul 15, 2025

Initiates: Buy

Price Target: $43

Current: $29.22

Upside: +47.16%

Revolution Medicines

Jul 15, 2025

Initiates: Buy

Price Target: $65

Current: $38.29

Upside: +69.76%

89bio

Mar 14, 2025

Initiates: Neutral

Price Target: $11

Current: $10.49

Upside: +4.86%